Periyasamy M, Patel H, Lai CF, Nguyen VT, Nevedomskaya E, Harrod A, et al. |
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Ac... |
Tuesday, September 29, 2015 |
Cell reports |
Permuth-Wey, J., Lawrenson, K., Shen, H. C., Velkova, A., Tyrer, J. P., Che... |
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31 |
|
Nature Communications, 4 |
Pertega-Gomes N, Felisbino S, Massie CE, Vizcaino JR, Coelho R, Sandi C, et... |
A glycolytic phenotype is associated with prostate cancer progression and a... |
Thursday, April 16, 2015 |
The Journal of pathology |
Pertega-Gomes N, Vizcaino JR, Felisbino S, Warren AY, Shaw G, Kay J, et al. |
Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein ov... |
Wednesday, June 3, 2015 |
Oncotarget |
Peterlongo P, Chang-Claude J, Moysich KB, Rudolph A, Schmutzler RK, Simard ... |
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and... |
Thursday, October 23, 2014 |
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology |
Peters CJ, Rees JR, Hardwick RH, Hardwick JS, Vowler SL, Ong CA, Zhang C, S... |
A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia |
|
Gastroenterology |
Pfister R, Bragelmann J, Michels G, Wareham NJ, Luben R, Khaw KT |
Performance of the CHARGE-AF risk model for incident atrial fibrillation in... |
Saturday, July 26, 2014 |
European journal of preventive cardiology |
Pharoah, P. D. P., Tsai, Y. -Y., Ramus, S. J., Phelan, C. M., Goode, E. L.,... |
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer |
|
Nature Genetics |
Philippou Y, Raja H, Gnanapragasam VJ |
Active surveillance of prostate cancer: a questionnaire survey of urologist... |
Sunday, June 14, 2015 |
BMC urology |
Phillips, K. A., Milne, R. L., Rookus, M. A., Daly, M. B., Antoniou, A. C.,... |
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers |
|
J Clin Oncol |